Skip to main content
. 2019 Nov 22;20(23):5862. doi: 10.3390/ijms20235862

Table 2.

In vitro antimicrobial activity and toxicity against mammalian cells of Cec-analogs.

Peptide (aa) Source Modification Antimicrobial Activity Peptide Conc. (μM)
Virus Bacteria Fungi Protozoa Cytotox. Hem Act.
SB-37 (38) [92] H. cecropia Cec B aa add./sub. - - - P. falciparum, T. cruzi - -
Shiva-1 (38) [46,92] H. cecropia Cec B aa add./sub. - G+, G− NA P. falciparum, T. cruzi - -
D-Cec B (35) [93] A. pernyi Cec B D-enantiomer - - A - - -
CecDH (32) [49] A. pernyi Cec B aa del. - G+, G− - - 25 100
ΔM1 (39) [55] G melonella Cec D N-term aa sub. - Sa (weak), Ec, Pa - - - 115
ΔM2 (39) [55] G melonella Cec D N-term aa sub. - Sa, Ec, Pa - - - ~60
Mdc–hly (?) [34] M. domestica Mdc; human Lysozyme Hybrid - G+, G− - - - -
CAMs (≤26) [94,95,96,97,98] H. cecropia Cec A; A. mellifera Mellitin Hybrids - G+, G− A Plasmodium 9 [96] [98]
Ac-CAMs (15) [99] H. cecropia Cec A; A. mellifera Mellitin N-term fatty acid acylation - Sa, Ec, Ab - L. pifanoi - -
CAM-W (26) [98] H. cecropia Cec A; A. mellifera Mellitin aa sub. - G+, G− A - - 3.12
CA-MAs (≤20) [100,101,102,103,104,105] H-cecropia Cec A; X. laevis Magainin 2 Hybrids with aa sub. virus–cell fusion inhibition G+, G− A - [105] [105]
CA-LL37 (22) [106] H-cecropia Cec A; human LL37 Hybrid - G+, G− - - - [106]
CecXJ-37C (37) [107] B. mori Cec B C-term aa add. - G+, G− - - 20 19
CecXJ-37N (37) [107] B. mori Cec B C-term aa add. - G+, G− - - 20 33

Peptide conc. (µM): Peptide concentration showing no or weak toxicity in mammalian cells; Cytotox.: Cytotoxicity; Hem act.: Hemolytic activity; sub.: Substitution; add.: Addition; del: Deletion; G+ Gram-positive bacteria; G−: Gram-negative bacteria; Sa: S. aureus; Ec: E. coli; Pa: P. aeruginosa; Ab: A. baumannii; A: Active against tested species; NA: Not active against the tested species; -: Not determined; (?): Not reported.